Anti-NFKBID Antibody

The polyclonal reagent from antibodies.com detects NFKBID (NF-kappa-B inhibitor delta, also called IkappaBNS), an atypical IkappaB-family regulator that shapes NF-kappaB signaling outcomes in immune cells. NFKBID expression is most prominent in lymphoid tissue, where it influences CD4+ T cell development, regulatory T cell maintenance, and the balance between tolerance and inflammatory activation. Studying this protein helps researchers trace how atypical IkappaB members fine-tune transcriptional responses that classical inhibitors such as IkB-alpha cannot fully explain.

This unconjugated IgG antibody is raised in rabbit and supplied as a 50 µl liquid aliquot, enough for multiple Western blot and immunohistochemistry experiments when used at standard working dilutions. Its broad reactivity across human, mouse, and rat samples makes it useful for comparative studies in tissue panels, primary cell lysates, and archived formalin-fixed sections, supporting translational work in inflammation, autoimmunity, and tumor immunology research where NF-kappaB pathway output is being dissected.